GENERAL COMMENTS
Thanks for the opportunity to review the manuscript. My major concern is the multivariate estimation of prevalence ratio (PR) in this study were adjusted only for gender and age while other significant variables such as smoking, alcohol and depressive symptoms were not included for multivariate estimation. In a literature search I have discovered two papers that may be relevant but have not been cited. 3. There are a few STROBE items missing which the authors might like to address.
VERSION 1 -AUTHOR RESPONSE
Reviewer 1 Comment: The authors used a population based cross-sectional study (page 1: line 31). Again they mentioned a three-stage cluster sampling design was chosen for the survey (page 3: line 22). It needs clarification why a population based study needs a sampling design. Our response: We corrected the abstract.
Comment: The authors mentioned one in every thirteen Brazilians uses sleeping pills (page 1 line 58)---The statement is wrong because the authors worked only on adult population. Our response: We corrected the abstract.
Comment: To find the associated factors of using sleeping pills (yes or no) I would prefer to present it by odds ratio instead of PR. It is because the authors mentioned the question is "over the past two weeks, have you used any sleeping pills?" Our response: The PR is more appropriate in cross-sectional studies because of considerable overestimation of the OR. Please check this reference: DOI: 10.1002/sim.7059.
Comment: The majority of participants were female and the mean age was 42.9 years (95% CI 42.7 to 43.2) (page 5). I am confused why the authors set the inclusion criteria of the subjects above age 18 then if 95% of the female lies within 42.7 and 43.2. Our response: The mean age reported was of the entire study population (males and females). We corrected this sentence.
Reviewer 2 Comment: Thanks for the opportunity to review the manuscript. My major concern is the multivariate estimation of prevalence ratio (PR) in this study were adjusted only for gender and age while other significant variables such as smoking, alcohol and depressive symptoms were not included for multivariate estimation. Our response: Thank you for your suggestion. In the first paper, sleeping pills were defined with the exclusion criteria. In the second paper, sleeping pills were not investigated.
Reviewer 3 Comment: This study addresses an interesting question on the prevalence of sleeping pill use in Brazil. The study appears well formulated, with robust and representative sampling of a large sample (though we are only give reference to another paper for details of how the sample was gathered).
Our response: The details of the sampling process were previously described in two papers, also available in English: http://www.scielo.br/pdf/ress/v24n2/en_2237-9622-ress-24-02-00207.pdf http://www.scielo.br/pdf/ress/v24n2/en_2237-9622-ress-24-02-00197.pdf Comment: It would contextualize the question asked if there was some brief information on sleeping medication use prevalence elsewhere (though this is provided in the Discussion), or on trends in prescribing, for example. Currently the Intro provides little background Our response: The introduction was reformulated.
Comment: Include a statement about how data were gathered (face-to-face; telephone, on line/website). Our response: This information is available in the "study design and sample" section: "The PNS consisted of household interviews conducted with adult residents with the aim of collecting data on health status, accessibility to public services, participation in prevention programs, and lifestyles of the population".
Comment: Were all questions completed by all respondents, as the paper implies? Our response: Yes, the data were collected with hand computers (PDA, personal digital assistance) that were programmed with the main questions included in this analysis.
Comment: What was the participation response/refusal rate? Our response: We included this information.
